An Olympics-style sports event that welcomes performance-enhancing drugs is set for later this month in Las Vegas. The company behind that endeavor just went public in a merger with a blank-check company, a SPAC deal that valued it at $1.2 billion with backing from Peter Thiel and former Coinbase CTO Balaji Srinivasan. Enhanced CEO Maximilian Martin joins Caroline Hyde from the floor of the New York Stock Exchange on "Bloomberg Tech."